← Back to headlines
Experimental mRNA Vaccine for Pancreatic Cancer Shows Promising Results
An experimental personalized mRNA vaccine for pancreatic cancer has shown promising results in clinical trials, with patients who responded to the vaccine remaining alive six years after therapy.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
